Miralda Salaji

Team Leader GMP Manufacturing / Operations at CUTISS

Miralda Salaji is a skilled professional in the field of biochemistry and tissue engineering, currently serving as the Team Leader GMP Manufacturing / Operations at CUTISS AG since March 2021. In this role, Miralda leads a production team focused on the planning and manufacturing of autologous skin grafts (“denovoSkin”) for both clinical and commercial use, while also supervising and training GMP Manufacturing Team members. Prior experience includes roles as a GMP Manufacturing Associate in Tissue Engineering at CUTISS AG, where detailed documentation and validation processes were undertaken, and academic projects at the German Center for Neurodegenerative Diseases and the Life and Medical Sciences Institute Bonn, highlighting expertise in immunocytochemistry, RNAi screening, and CRISPR/Cas9 gene editing. Miralda holds a Master of Science in Biochemistry from The University of Bonn and a Bachelor of Science in Biochemistry from the University of Tübingen.

Links


Org chart


Teams


Offices

This person is not in any offices


CUTISS

CUTISS AG can now bio-engineer large quantities of individually customized human skin grafts, denovoSkin™, starting off from a very small piece of healthy patient’s skin. Because of its intrinsic characteristics, denovoSkin™ is expected to result in a minimally scarring outcome after transplantation. denovoSkin™ received a Swissmedic, EMA and FDAOrphan drug designation for the treatment of burns.


Employees

11-50

Links